comparemela.com

Board Kevin Dalton News Today : Breaking News, Live Updates & Top Stories | Vimarsana

CareRx is a Buy, says Desjardins

Desjardins Capital Markets analyst Gary Ho maintained a “Buy” rating on CareRx stock in a Monday report.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.